Health Affairs October 25, 2024
Caroline Marra, Amy P. Abernethy, Sean R. Tunis

Medicare has recently endorsed the concept of “fit-for-purpose” (FFP) studies to support ongoing evidence generation as a condition of coverage for selected emerging medical products. In part 1 of this article, we offered a framework to help apply a structured approach to FFP study design and data source selection in the context of coverage with evidence development (CED), which provides for Medicare coverage of selected emerging medical products with the condition that they are furnished in the context of Medicare-approved clinical studies.

In part 2 below, we illustrate the potential impact of our framework by examining how it might have affected two applications of CED by the Centers for Medicare and Medicaid Services (CMS): the proposed use of CED in...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: CMS, Govt Agencies, Insurance, Medical Devices, Medicare
Hospitals urge lawmakers to act as Medicare telehealth policies near expiration
Small practices, individual radiologists at a disadvantage in Medicare quality pay program
CMS Issues Final Rule on Returning Medicare and Medicaid Overpayments
Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023
Medicare Part D spending on weight loss drugs surges 364%: OIG

Share This Article